Levodopa pharmacokinetics and pharmacodynamics in fluctuating parkinsonian patients
- 1 June 1986
- journal article
- research article
- Published by Wolters Kluwer Health in Neurology
- Vol. 36 (6) , 739
- https://doi.org/10.1212/wnl.36.6.739
Abstract
We investigated levodopa intravenous infusion rates, plasma concentrations, and clinical responses in 23 parkinsonian patients with a fluctuating response to the drug. There was a linear relationship between rate of levodopa infusion and plasma concentration when carbidopa was coadministered. Minimum-therapeutically effective plasma concentrations of levodopa ranged from 3 to 12 nmol/ml. The duration, but not the magnitude, of clinical response was linearly related to plasma concentrations. The clinical response lagged behind the rise and fall of plasma levodopa. There was no evidence of idiosyncratic pharmacokinetic or pharmacodynamic responses to levodopa to explain the fluctuating response.This publication has 7 references indexed in Scilit:
- The effect of carbidopa on the pharmacokinetics of intravenously administered levodopa: The mechanism of action in the treatment of parkinsonismAnnals of Neurology, 1985
- Control of on/off phenomenon by continuous intravenous infusion of levodopaNeurology, 1984
- ?On-off? phenomenon in Parkinson's disease: Correlation to the concentration of dopa in plasmaJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1984
- The “On–Off” Phenomenon in Parkinson’s DiseaseNew England Journal of Medicine, 1984
- Plasma levodopa, dopamine and therapeutic response following levodopa therapy of Parkinsonian patientsJournal of the Neurological Sciences, 1980
- Changes in Neostriatal Dopamine Concentrations in Response to Levodopa InfusionsJournal of Neurochemistry, 1980
- Plasma DOPA levels and growth hormone response to levodopa in parkinsomism.Journal of Neurology, Neurosurgery & Psychiatry, 1977